{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_174415.2:c.6053G>A",
          "cDNA Change": {
            "transcript": "NM_174415.2",
            "ref": "G",
            "alt": "A",
            "position": "6053"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S variant in LRRK2"
        }
      ]
    },
    {
      "Gene": "APP",
      "variants": [
        {
          "HGVS": "NM_001045150.2:c.2008A>T;NM_001045150.2:c.2011A>T",
          "cDNA Change": {
            "transcript": "NM_001045150.2",
            "ref": "A",
            "alt": "T",
            "position": "2008"
          },
          "Protein Change": {
            "ref": "K",
            "alt": "N",
            "position": "670"
          },
          "Description in input context": "Swedish mutation (K670N/M671L) in APP"
        }
      ]
    },
    {
      "Gene": "CFTR",
      "variants": [
        {
          "HGVS": "NM_000492.3:c.1521_1523delTAA",
          "cDNA Change": {
            "transcript": "NM_000492.3",
            "ref": "TAA",
            "alt": "",
            "position": "1521-1523"
          },
          "Protein Change": {
            "ref": "F",
            "alt": "",
            "position": "508"
          },
          "Description in input context": "ΔF508 variant in CFTR"
        }
      ]
    },
    {
      "Gene": "BRCA1",
      "variants": [
        {
          "HGVS": "NM_007294.3:c.5078A>G",
          "cDNA Change": {
            "transcript": "NM_007294.3",
            "ref": "A",
            "alt": "G",
            "position": "5078"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "Q",
            "position": "1693"
          },
          "Description in input context": "E1693Q variant in BRCA1"
        }
      ]
    },
    {
      "Gene": "SLC6A2",
      "variants": [
        {
          "HGVS": "NM_001033142.2:c.1382G>A",
          "cDNA Change": {
            "transcript": "NM_001033142.2",
            "ref": "G",
            "alt": "A",
            "position": "1382"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "H",
            "position": "461"
          },
          "Description in input context": "R461H variant in SLC6A2"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005313"
  },
  "Experiment Method": [
    {
      "Assay Method": "Kinase activity assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells overexpressing LRRK2-G2019S were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_174415.2:c.6053G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased phosphorylation of LRRK2 substrates in cells expressing G2019S."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as a negative control."
      },
      "Statistical method": "ANOVA with post-hoc Tukey's test",
      "Threshold": "p < 0.05",
      "Approved assay": "Yes"
    },
    {
      "Assay Method": "Aβ42 secretion assay",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "APP-Swedish mutation expressing cells",
        "Description": "Primary neurons expressing APP-K670N/M671L were cultured."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001045150.2:c.2008A>T;NM_001045150.2:c.2011A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Increased Aβ42 secretion levels compared to wild-type APP."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type APP was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "APP-null cells were used as a negative control."
      },
      "Statistical method": "Student's t-test",
      "Threshold": "p < 0.01",
      "Approved assay": "Yes"
    },
    {
      "Assay Method": "Ion transport assay",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "CFBE41o- cells",
        "Description": "CFBE41o- cells expressing ΔF508-CFTR were cultured."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000492.3:c.1521_1523delTAA",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Reduced chloride ion flux compared to wild-type CFTR-expressing cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type CFTR was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as a negative control."
      },
      "Statistical method": "ANOVA with post-hoc Dunnett's test",
      "Threshold": "p < 0.05",
      "Approved assay": "Yes"
    },
    {
      "Assay Method": "DNA repair assay (comet assay)",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "BRCA1-E1693Q expressing cells",
        "Description": "BRCA1-E1693Q-expressing cells were cultured."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_007294.3:c.5078A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Increased DNA damage measured by comet tail length compared to wild-type BRCA1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type BRCA1 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "BRCA1-null cells were used as a negative control."
      },
      "Statistical method": "Student's t-test",
      "Threshold": "p < 0.05",
      "Approved assay": "Yes"
    },
    {
      "Assay Method": "Behavioral assay (locomotor activity)",
      "Material used": {
        "Material Source": "Animal model",
        "Material Name": "SLC6A2-R461H transgenic mice",
        "Description": "Transgenic mice expressing SLC6A2-R461H were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001033142.2:c.1382G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "dominant-negative",
          "Result Description": "Reduced locomotor activity in R461H mice compared to wild-type mice."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SLC6A2 mice were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "SLC6A2 knockout mice were used as a negative control."
      },
      "Statistical method": "ANOVA with post-hoc Bonferroni correction",
      "Threshold": "p < 0.05",
      "Approved assay": "Yes"
    }
  ]
}